Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Sequalae Caused by Post-acute Sequelae of SARS (Severe Acute Respiratory Syndrome)-CoV-2 Infection

NCT04846010 is registered in ClinicalTrials.gov with All Natural Medicine Clinic, LLC as lead sponsor.

NCT NCT04846010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04846010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Sequalae Caused by Post-acute Sequelae of SARS (Severe Acute Respiratory Syndrome)-CoV-2 Infection
Lead sponsor
All Natural Medicine Clinic, LLC
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 1, 2021
Completion date
October 1, 2022
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depression, depression, anxiety, depression, bipolar, gastro esophageal reflux, gerd, glomerulonephritis, hepatitis, insomnia, post infection glomerulonephritis, post infectious osteoarthritis, post-infectious arthritis, post-infectious disorder (disorder), post-infectious hypothyroidism, post-infectious parkinsonism, post-infectious peripheral neuralgia, post-infectious polyneuritis, sequelae of; infection